V. Bryan Lawlis, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 16,720 shares at $76.52 ($1.3M) on 2020-03-16, disclosed to the SEC on 2020-03-18.
Open-market sale of $1.3M BMRN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.52 | 4,610 | $353K | 27.8% |
| 2 | $76.52 | 4,610 | $353K | 27.8% |
| 3 | $75.39 | 3,750 | $283K | 22.2% |
| 4 | $75.39 | 3,750 | $283K | 22.2% |
| Total | $76.01 avg | 16,720 | $1.3M | 100% |
| Filing → |
| GERN | SELL | 2023-05-11 | $105K | — | Filing → |
| BMRN | SELL | 2023-04-04 | $825K | — | Filing → |
| BMRN | SELL | 2022-04-18 | $356K | — | Filing → |